SVCT.L (Seneca Growth Capital VCT plc) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for SVCT.L and 80,000+ other tickers.
See exactly how SVCT.L's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for SVCT.L and 80,000+ other tickers.
Seneca Growth Capital VCT plc operates as a venture capital trust, primarily focusing on providing growth-stage financing. The trust allocates capital to emerging biotechnology firms, with a strong inclination towards both unlisted and publicly traded companies within the MedTech industry. Its investment scope extends geographically across the United Kingdom, the French regions of Île-de-France and Burgundy, and other mature European markets. Financially, the fund typically targets businesses boasting annual revenues exceeding £10 million (around $11.90 million), a gross profit margin greater than 50%, and an operating profit margin above 10%.
No recent news available.